InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Puromycin | Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenog... | 2022 | Cancer Genomics Proteomics | Sanchez A. et al. | DOI: 10.21873/cgp.20324 |
| A549-Dual™ KO-RIG-I Cells | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
| Plasmocin® - Mycoplasma Elimination Reagent | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
| A549-Dual™ Cells | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
| QUANTI-Luc™: Luciferase Detection Reagent | Robust delivery of RIG-I agonists using extracellular vesicles for anti-cance... | 2022 | J Extracell Vesicles | Peng B. et al. | DOI: 10.1002/jev2.12187 |
| Anti-mouse Mincle (CLEC4E) antibody | Recognition of Tumor Nidogen-1 by Neutrophil C-Type Lectin Receptors. | 2022 | Biomedicines | Sionov R.V. et al. | DOI: 10.3390/biomedicines10040908 |
| Anti-mouse Dectin-1 (CLEC7A) antibody | Recognition of Tumor Nidogen-1 by Neutrophil C-Type Lectin Receptors. | 2022 | Biomedicines | Sionov R.V. et al. | DOI: 10.3390/biomedicines10040908 |
| CL075 (3M002) | Monocyte subset redistribution from blood to kidneys in patients with Puumala... | 2022 | PLoS Pathog. | Vangeti S. et al. | DOI: 10.1371/journal.ppat.1009400 |
| Alhydrogel® adjuvant 2% | A recombinant alpha-like protein subunit vaccine (GBS-NN) provides protection... | 2022 | J Infect Dis | Brokaw A. et al. | DOI: 10.1093/infdis/jiac148 |
| ODN 2395 - TLR9 ligand | Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum b... | 2022 | J Immunol Methods | Quach H.Q. et al. | DOI: 10.1016/j.jim.2022.113275 |
| Primocin® | Epidermal growth factor receptor signaling in precancerous keratinocytes prom... | 2022 | Mol Carcinog. | Nguyen K.A. et al. | DOI: 10.1002/mc.23409 |
| pFUSE-mIgG2a-Fc | A Single-Domain TCR-like Antibody Selective for the Qa-1 b/Qdm Peptide Comple... | 2022 | J Immunol. | Ghaffari S. et al. | DOI: 10.4049/jimmunol.2100790 |
| Puromycin | Elevated Expression of miR-200c/141 in MDA-MB-231 Cells Suppresses MXRA8 Leve... | 2022 | Genes (Basel). | Simpson K.E. et al. | DOI: 10.3390/genes13040691 |
| J774-Dual™ Cells | Anti-tumor immunity by transcriptional synergy between TLR9 and STING activat... | 2022 | Int Immunol. | Temizoz B. et al. | DOI: 10.1093/intimm/dxac012 |
| Quil-A® adjuvant | An amyloid beta vaccine that safely drives immunity to a key pathological spe... | 2022 | Brain Commun. | Vukicevic M. et al. | DOI: 10.1093/braincomms/fcac022 |
| Alhydrogel® adjuvant 2% | Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycop... | 2022 | Vaccines (Basel) | Li J. et al. | DOI: 10.3390/vaccines10040529 |
| QUANTI-Blue™ | A computational approach to unraveling TLR signaling in murine mammary carcin... | 2022 | DOI: 10.1016/j.compbiomed.2017.12.013 | Liew C.W. et al. | Comput Biol Med. |
| THP1-Blue™ NF-κB Cells | A computational approach to unraveling TLR signaling in murine mammary carcin... | 2022 | DOI: 10.1016/j.compbiomed.2017.12.013 | Liew C.W. et al. | Comput Biol Med. |
| FLA-PA Ultrapure | Cilia Stimulatory and Antibacterial Activities of T2R Bitter Taste Receptor A... | 2022 | Pharmaceuticals (Basel) | Kuek L.E. et al. | DOI: 10.3390/ph15040452 |
| Primocin® | Rapid establishment of human colonic organoid knockout line. | 2022 | STAR Protoc. | Gu W. et al. | DOI: 10.1016/j.xpro.2022.101308 |